The FDA provided guidance on the design of the APOLLO post-marketing confirmatory trial, which will support an accelerated approval filing for bitopertin. Disc plans to submit a New Drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback